SOHAN HEALTHCARE PRIVATE LTD

Overview

SOHAN HEALTHCARE PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 11 active FDA Type II Drug Master Files, covering APIXABAN; ISOXSUPRINE HYDROCHLORIDE; LINEZOLID (FORM-II); LINEZOLID (FORM-III); METFORMIN HYDROCHLORIDE USP; METHIMAZOLE USP.

API / Drug Master Files

SOHAN HEALTHCARE PRIVATE LTD holds 11 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• METHIMAZOLE USPActive2026-03-27
• SOTALOL HYDROCHLORIDE USPActive2026-02-27
• RIVAROXABANActive2026-01-23
• LINEZOLID (FORM-III)Active2025-11-28
• LINEZOLID (FORM-II)Active2025-11-27
• APIXABANActive2025-08-27
• SALMETEROL XINAFOATE IP/BPActive2013-02-04
• ISOXSUPRINE HYDROCHLORIDEActive2013-01-28
• NICOTINE POLACRILEX 20% USPActive2010-06-17
• NICOTINE USPActive2010-02-07
• METFORMIN HYDROCHLORIDE USPActive2008-04-09

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SOHAN HEALTHCARE PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.